Biotechnology

Exact Sciences showcases robust Q3 results, marking a turning point with increased revenue, diversified streams, and an upward trajectory.

EXACT Sciences eyes a pivotal moment with its upcoming Q3 earnings report. The firm excels in ESG ratings and revenue, but operational costs raise...

Vivek Ramaswamy is a new force in US politics, having risen to second place in the race for the Republican nomination. But who is Vivek Ramaswamy...

What can biotech penny stocks do for you? While investors might be attracted by the potential for outsize returns, there are serious risks to...

New drugs and treatments have to undergo a long process of development, clinical trials and FDA approvals before they can start bringing in revenue...

Discover the cutting-edge world of biopharmaceuticals and how it's reshaping healthcare. From advanced therapies to life-changing drugs, explore...

Explore the McKinsey Helix Report and discover insights into the future success of the biopharmaceutical industry.

Explore how Bristol-Myers Squibb pioneers cancer treatment using precision medicine & immunotherapy for improved patient outcomes and survival rates.

Biotech outfit Kymera Therapeutics (NASDAQ: KYMR) is heading upwards on the back of positive clinical trial news. But is KYMR stock a good investment?

The Ginkgo Bioworks (NYSE: DNA) share price is beaten down this year. We look at whether DNA Stock is a good buy.

The upcoming IPOs in focus this week include lab-grown organ outfit BioLife4D Corp, non-lethal weapons developer Kwesst and AI healthcare...

Shares of Veeva Systems Inc (NYSE: VEEV) are markedly lower on Friday on the back of earnings disappointment. But with few competitors and a...

Horizon Therapeutics (NASDAQ: HZNP) has seen its share price leap on the back of M&A news, but does that mean HZNP stock is a good investment?

Iveric Bio Inc (NASDAQ: ISEE) has seen its share price leap following a new FDA designation. However, with good news for a key competitor emerging...

The IPOs to look out for this week include cancer treatment outfit Genelux Corporation and medicine development and AI specialist BullFrog AI.

Berkeley Lights (NASDAQ: BLI) released Q3 earnings with record recurring revenues, leading the BLI share price to rise 20%.